Industry Trends

Examining CMS’s National Health Expenditure Estimates for 2024

U.S. healthcare spending has followed a sustained upward trajectory for decades, and current projections indicate that this growth will continue. As of 2024, total spending reached $5.3T and is expected to rise to $8.6T by 2033, a 63.1% increase. Outside of a pandemic-era peak of 19.7% in 2020, healthcare spending had represented a relatively stable […]

Examining CMS’s National Health Expenditure Estimates for 2024 Read More »

Quarterly Healthcare Transactions Review: Unveiling the Latest Industry M&A (Q4 2025)

Ankura is pleased to present an overview of healthcare services transactions announced or closed during Q4 2025 in the United States. Total transactions increased by 2.6% in the fourth quarter of 2025 after decreasing by 2.0% in the third quarter. However, compared to Q4 2024, transaction volumes for Q4 2025 were down by 5.2%. Recent

Quarterly Healthcare Transactions Review: Unveiling the Latest Industry M&A (Q4 2025) Read More »

2026 DOJ and State AG Enforcement Trends for Health Care and Life Sciences

Health care and life sciences enforcement is a top priority in 2026, and the playbook is becoming both broader and more coordinated. Federal prosecutors and state attorneys general are continuing to press traditional fraud and abuse theories, but they are doing so with more sophisticated data tools, more frequent multi-agency actions and a willingness to

2026 DOJ and State AG Enforcement Trends for Health Care and Life Sciences Read More »

From Gridlock to Green Shoots: 2026 M&A Healthcare Market

In this episode of Solomon Connects, Solomon Partners’ Head of Healthcare Jon Hammack joins M&A Director Chris Moynihan to unpack the current state of the healthcare M&A market and the key themes shaping a more constructive deal environment this year. Jon shares insights on sponsor and strategic dynamics, record pipelines, improving market clarity, and the

From Gridlock to Green Shoots: 2026 M&A Healthcare Market Read More »

Navigating Healthcare M&A in 2026: Advancing Deal Execution through Regulatory Strategy

Partners in Ropes & Gray’s health care group share their insights about the healthcare M&A market and how the regulatory landscape is shaping deal structure and execution, especially in multistate and highly regulated environments. The partners also offer practical strategies in navigating regulatory requirements to execute healthcare M&A transactions successfully. Read the full article: Navigating

Navigating Healthcare M&A in 2026: Advancing Deal Execution through Regulatory Strategy Read More »

Scroll to Top